BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19588483)

  • 1. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.
    Lui VW; Wong EY; Ho Y; Hong B; Wong SC; Tao Q; Choi GC; Au TC; Ho K; Yau DM; Ma BB; Hui EP; Chan AS; Tsang CM; Tsao SW; Grandis JR; Chan AT
    Int J Cancer; 2009 Oct; 125(8):1884-93. PubMed ID: 19588483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation.
    Lui VW; Yau DM; Cheung CS; Wong SC; Chan AK; Zhou Q; Wong EY; Lau CP; Lam EK; Hui EP; Hong B; Hui CW; Chan AS; Ng PK; Ng YK; Lo KW; Tsang CM; Tsui SK; Tsao SW; Chan AT
    Oncogene; 2011 Mar; 30(13):1518-30. PubMed ID: 21119603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.
    Kong QL; Hu LJ; Cao JY; Huang YJ; Xu LH; Liang Y; Xiong D; Guan S; Guo BH; Mai HQ; Chen QY; Zhang X; Li MZ; Shao JY; Qian CN; Xia YF; Song LB; Zeng YX; Zeng MS
    PLoS Pathog; 2010 Jun; 6(6):e1000940. PubMed ID: 20532215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells.
    Zhang G; Tsang CM; Deng W; Yip YL; Lui VW; Wong SC; Cheung AL; Hau PM; Zeng M; Lung ML; Chen H; Lo KW; Takada K; Tsao SW
    PLoS One; 2013; 8(5):e62284. PubMed ID: 23658720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mobility group box 1 (HMGB1) is upregulated by the Epstein-Barr virus infection and promotes the proliferation of human nasopharyngeal carcinoma cells.
    Zhu X; Sun L; Wang Y
    Acta Otolaryngol; 2016; 136(1):87-94. PubMed ID: 26382001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
    Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
    Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral IL-10 promotes cell proliferation and cell cycle progression via JAK2/STAT3 signaling pathway in nasopharyngeal carcinoma cells.
    Ren Y; Yang J; Li M; Huang N; Chen Y; Wu X; Wang X; Qiu S; Wang H; Li X
    Biotechnol Appl Biochem; 2020 Nov; 67(6):929-938. PubMed ID: 31737947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells.
    Fang CY; Lee CH; Wu CC; Chang YT; Yu SL; Chou SP; Huang PT; Chen CL; Hou JW; Chang Y; Tsai CH; Takada K; Chen JY
    Int J Cancer; 2009 May; 124(9):2016-25. PubMed ID: 19132751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.
    Ma L; Deng X; Wu M; Zhang G; Huang J
    FEBS Lett; 2014 May; 588(9):1562-70. PubMed ID: 24613926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
    Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
    Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
    Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
    J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.
    Chiu SH; Wu CC; Fang CY; Yu SL; Hsu HY; Chow YH; Chen JY
    Oncotarget; 2014 Sep; 5(18):8583-601. PubMed ID: 25261366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma.
    Hsu CY; Yi YH; Chang KP; Chang YS; Chen SJ; Chen HC
    PLoS Pathog; 2014 Feb; 10(2):e1003974. PubMed ID: 24586173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.